NIH: Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell Lymphoma
June 21, 2024
June 21, 2024
WASHINGTON, June 21 (TNSres) -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release on June 20, 2024:
* * *
Combination therapy developed by NIH researchers demonstrates the power of precision medicine.
* * *
Researchers at the National Institutes of Health (NIH) have developed a non-chemotherapy treatment regimen that is achieving full remissions for some people with aggressive . . .
* * *
Combination therapy developed by NIH researchers demonstrates the power of precision medicine.
* * *
Researchers at the National Institutes of Health (NIH) have developed a non-chemotherapy treatment regimen that is achieving full remissions for some people with aggressive . . .